| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), RNA's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 138.7K | $1.24M | - | |
| Other | 119.7K | $1.07M | - | |
| Other | 116.9K | $8.44M | - | |
| Other | 79.0K | - | - | |
| Other | 74.6K | $5.39M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 3, 2025 | Gallagher Kathleen P. | Chief Program Officer | Sale+OE | 5,875 | $32.16 | $188,918.26 | -10.4% | |
| Jan 22, 2025 | Gallagher Kathleen P. | Chief Program Officer | Sell | 9,411 | $29.53 | $277,912.09 | -15.7% | |
| Jan 21, 2025 | Hughes Steven George | Chief Medical Officer | Sell | 3,947 | $28.59 | $112,856.48 | -4.6% | |
| Jan 21, 2025 | Boyce Sarah | President and CEO | Sell | 10,397 | $28.59 | $297,291.42 | -3.0% | |
| Jan 21, 2025 | Flanagan W. Michael | Chief Scientific Officer | Sell | 5,672 | $28.60 | $162,191.97 | -5.8% | |
| Jan 21, 2025 | McCarthy Teresa | Chief Human Resources Officer | Sell | 2,959 | $28.59 | $84,611.50 | -2.7% | |
| Jan 21, 2025 | MacLean Michael F | Chief Financial Officer | Sell | 3,287 | $28.59 | $93,985.36 | -3.0% | |
| Jan 21, 2025 | Levin Arthur A | Director | Sell | 1,872 | $28.60 | $53,536.77 | -12.6% | |
| Dec 18, 2024 | McCarthy Teresa | Chief Human Resources Officer | Sell | 11,151 | $32.66 | $364,191.66 | -11.9% | |
| Dec 18, 2024 | Boyce Sarah | President and CEO | Sell | 31,855 | $32.66 | $1,040,384.30 | -10.7% |